![](https://jlpp.org/wp-content/uploads/2020/11/MB_IS1.png)
Patent Rights in a Pandemic: Does the Race for a Covid-19 Vaccine Mean Inequitable Access?
November 6, 2020Archives . Authors . Blog News . Certified Review . Feature . Feature Img . Issue Spotters . Policy/Contributor Blogs . Recent Stories . Student Blogs Article(Source) The coronavirus pandemic has changed life as we know it. The world has come a long way since the initial outbreak, but the uncertainty surrounding a potential Covid-19 vaccine persists. Even with mounting uncertainty, the demand for a safe and effective vaccine continues to increase. The Food and Drug Administration’s approvals and authorizations
![](https://jlpp.org/wp-content/uploads/2020/06/PremrajIS.jpg)
Diagnostic Methods as a Category of Patent-Ineligible Subject Matter
June 22, 2020Archives . Authors . Blog News . Certified Review . Feature . Feature Img . Issue Spotters . Note Adaptation . Notes . Policy/Contributor Blogs . Recent Stories . Student Blogs Article(Source) The authority to grant to patents arises from Article Eight of the United States Constitution. Specifically, Clause Eight grants Congress the power to “promote the Progress of Science and useful Arts, by securing for limited Times to Authors and inventors the exclusive right to their respective Writings and Discoveries.” Through this clause, Congress is